This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magez, S.
Right arrow Articles by De Baetselier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magez, S.
Right arrow Articles by De Baetselier, P.

 Previous Article  |  Next Article 

Infection and Immunity, March 2002, p. 1342-1351, Vol. 70, No. 3
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.3.1342-1351.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Control of Experimental Trypanosoma brucei Infections Occurs Independently of Lymphotoxin-{alpha} Induction

S. Magez,1* B. Stijlemans,1 G. Caljon,1 H.-P. Eugster,2 and P. De Baetselier1

Department of Immunology, Parasitology and Ultrastructure, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Paardenstraat 65, B-1640 Sint Genesius Rode, Belgium,1 Section of Clinical Immunology, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland2

Received 6 September 2001/ Returned for modification 9 October 2001/ Accepted 29 November 2001

Trypanosome infections are marked by severe pathological features, including anemia, splenomegaly, and suppression of T-cell proliferation. We have used lymphotoxin-{alpha}-deficient (LT-{alpha}-/-) mice, as well as LT-{alpha}-tumor necrosis factor-double-deficient (LT-{alpha}-/- TNF-/-) mice, to analyze the contributions of these related cytokines in both induction of trypanosomosis-associated immunopathology and infection control. Moreover, as the cytokine-deficient mice used have no detectable lymph nodes and lack germinal-center formation upon immune stimulation, we have analyzed the functional importance of both the lymph nodes and spleen during experimental Trypanosoma brucei infections. First, we show that the absence of LT-{alpha} does not significantly alter early trypanosomosis development or pathology but does result in better control of late-stage parasitemia levels and slightly prolonged survival. This increased survival of infected LT-{alpha}-/- mice coincides with the appearance of increased chronic-stage anti-trypanosome immunoglobulin M (IgM)-IgG2a serum titers that are generated in the absence of functional peripheral lymphoid tissue and do not require germinal-center formation. Second, we show that splenectomized mice control their parasitemia to the same extent as fully immune-competent littermates. Finally, using LT-{alpha}-/- TNF-/- double-deficient mice, we show that in these mice T. brucei infections are very well controlled during the chronic infection stage and that infection-induced pathology is minimized. Together, these findings indicate that while increased IgM-IgG2a anti-trypanosome antibody titers (generated in the absence of LT-{alpha}, peripheral lymph nodes, and germinal-center formation) coincide with improved parasitemia control, it is TNF that has a major impact on trypanosomosis-associated immunopathology.


* Corresponding author. Mailing address: Department of Immunology, Parasitology and Ultrastructure, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Paardenstraat 65, B-1640 Sint Genesius Rode, Belgium. Phone: 32.2.359.03.01. Fax: 32.2.359.03.59. E-mail: stemagez{at}vub.ac.be.


Infection and Immunity, March 2002, p. 1342-1351, Vol. 70, No. 3
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.3.1342-1351.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Rathkolb, B., Noyes, H. A., Brass, A., Dark, P., Fuchs, H., Gailus-Durner, V., Gibson, J., de Angelis, M. H., Ogugo, M., Iraqi, F., Kemp, S. J., Naessens, J., Pope, M. E., Wolf, E., Agaba, M. (2009). Clinical Chemistry of Congenic Mice with Quantitative Trait Loci for Predicted Responses to Trypanosoma congolense Infection. Infect. Immun. 77: 3948-3957 [Abstract] [Full Text]  
  • Couper, K. N., Blount, D. G., Riley, E. M. (2008). IL-10: The Master Regulator of Immunity to Infection. J. Immunol. 180: 5771-5777 [Abstract] [Full Text]  
  • Stijlemans, B., Baral, T. N., Guilliams, M., Brys, L., Korf, J., Drennan, M., Van Den Abbeele, J., De Baetselier, P., Magez, S. (2007). A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology. J. Immunol. 179: 4003-4014 [Abstract] [Full Text]  
  • Caljon, G., Van Den Abbeele, J., Stijlemans, B., Coosemans, M., De Baetselier, P., Magez, S. (2006). Tsetse Fly Saliva Accelerates the Onset of Trypanosoma brucei Infection in a Mouse Model Associated with a Reduced Host Inflammatory Response. Infect. Immun. 74: 6324-6330 [Abstract] [Full Text]  
  • Spahn, T. W., Eugster, H.-P., Fontana, A., Domschke, W., Kucharzik, T. (2005). Role of Lymphotoxin in Experimental Models of Infectious Diseases: Potential Benefits and Risks of a Therapeutic Inhibition of the Lymphotoxin-{beta} Receptor Pathway. Infect. Immun. 73: 7077-7088 [Full Text]  
  • Engwerda, C. R., Ato, M., Stager, S., Alexander, C. E., Stanley, A. C., Kaye, P. M. (2004). Distinct Roles for Lymphotoxin-{alpha} and Tumor Necrosis Factor in the Control of Leishmania donovani Infection. Am. J. Pathol. 165: 2123-2133 [Abstract] [Full Text]  
  • Schluter, D., Kwok, L.-Y., Lutjen, S., Soltek, S., Hoffmann, S., Korner, H., Deckert, M. (2003). Both Lymphotoxin-{alpha} and TNF Are Crucial for Control of Toxoplasma gondii in the Central Nervous System. J. Immunol. 170: 6172-6182 [Abstract] [Full Text]